Allstate Corp Takes $1.18 Million Position in Humana Inc. $HUM

Allstate Corp purchased a new position in Humana Inc. (NYSE:HUMFree Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 4,524 shares of the insurance provider’s stock, valued at approximately $1,177,000.

Other hedge funds have also recently bought and sold shares of the company. Elevation Point Wealth Partners LLC acquired a new stake in Humana in the second quarter valued at $32,000. Mather Group LLC. purchased a new stake in shares of Humana in the 3rd quarter worth about $34,000. AlphaCore Capital LLC acquired a new stake in Humana in the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC increased its holdings in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 48 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its position in Humana by 19,300.0% during the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after acquiring an additional 193 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HUM. KeyCorp reiterated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Guggenheim reiterated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Zacks Research cut Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Barclays restated an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Finally, Morgan Stanley reiterated an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $293.37.

Check Out Our Latest Analysis on Humana

Humana Stock Performance

NYSE:HUM opened at $270.32 on Thursday. The company has a market cap of $32.51 billion, a P/E ratio of 25.33, a P/E/G ratio of 2.21 and a beta of 0.45. The firm’s 50 day moving average is $257.11 and its two-hundred day moving average is $264.26. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the firm posted $4.16 EPS. Analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.